ClosetInvestor, CytoDyn Reaches Enrollment of 1
Post# of 148187
(Total Views: 572)
Posted On: 10/01/2020 6:41:10 PM
Re: ClosetInvestor #59011
ClosetInvestor,
CytoDyn Reaches Enrollment of 195 Patients in its Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms: Aug 25, 2020
220 patients @ September 30.
So 25 patients in app. 35 days. Enrollment must speed up and that is what we were told will happen in conference.
CytoDyn Reaches Enrollment of 195 Patients in its Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms: Aug 25, 2020
220 patients @ September 30.
So 25 patients in app. 35 days. Enrollment must speed up and that is what we were told will happen in conference.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼